Treatment of Chickenpox in a 16-Year-Old Weighing 46 kg
Oral acyclovir 800 mg four times daily for 5-7 days should be initiated within 24 hours of rash onset for this adolescent patient with chickenpox.
Rationale for Treatment
At 16 years old, this patient falls into the high-risk category for moderate to severe varicella. Adolescents (≥12 years) have significantly increased morbidity and complication rates compared to younger children, making antiviral therapy clinically justified 1.
Specific Dosing Regimen
For this 46 kg adolescent:
- Acyclovir 800 mg orally four times daily for 5-7 days 2
- Must be started within 24 hours of rash onset for maximum benefit 1, 3
- Treatment initiated after 24 hours has substantially reduced efficacy
The weight-based dosing (20 mg/kg/dose, maximum 800 mg) would calculate to 920 mg, but the standard maximum dose of 800 mg per dose is appropriate and FDA-approved for this age group 2, 3.
Expected Clinical Benefits
When started within 24 hours of rash onset, acyclovir provides:
- Reduction in fever duration by 1-1.3 days (median 1 day vs 2 days without treatment) 3, 4
- Faster cutaneous healing (median 2 days vs 3 days to cessation of new lesions) 3
- Fewer total skin lesions (median 336 vs 500 lesions) 3
- Reduced severity of constitutional symptoms and pruritus 1, 5
Important Limitations
Acyclovir does NOT reduce:
- Transmission to household contacts 1
- Duration of school absence 1
- Complication rates in otherwise healthy patients (complications occur in only 1-2% regardless of treatment) 1
However, the clinical benefit of symptom reduction and accelerated healing is considered sufficient to justify treatment in adolescents, who experience more severe disease than younger children 1.
Supportive Care
In addition to acyclovir:
- Antipyretics for fever (avoid aspirin due to Reye's syndrome risk)
- Antihistamines for pruritus management
- Maintain hydration
- Monitor for secondary bacterial superinfection of lesions
Critical Timing Consideration
The 24-hour window from rash onset is crucial—if the patient presents beyond this timeframe, the evidence for benefit becomes substantially weaker, though some experts still recommend treatment in adolescents given their higher baseline risk 1, 5.
When to Escalate Care
Seek immediate evaluation if:
- Respiratory symptoms develop (varicella pneumonitis)
- Signs of bacterial superinfection (increasing erythema, warmth, purulent drainage)
- Neurological symptoms (altered mental status, severe headache, ataxia)
- Immunocompromised status (would require IV acyclovir 10 mg/kg every 8 hours instead) 2
Antibody Response
Acyclovir treatment does not impair long-term antibody development—while titers may be slightly lower at 4 weeks post-infection, they equalize by 1 year and provide equivalent long-term immunity 3.